Epanova FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 5, 2014)
Brand name: Epanova
Generic name: omega-3-carboxylic acids
Dosage form: Capsules
Company: AstraZeneca
Treatment for: Hypertriglyceridemia
Marketing Status: Discontinued
Epanova (omega-3-carboxylic acids) is a fish oil-derived mixture of free fatty acids for the treatment of patients with severe hypertriglyceridemia.
Development timeline for Epanova
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
